MedPath

Clinical Investigation of a New Intraocular Lens

Not Applicable
Completed
Conditions
Cataract
Interventions
Device: TECNIS Symfony Extended Range of Vision IOL, Model ZXR00
Device: TECNIS Monofocal IOL, Model ZCB00
Registration Number
NCT02203721
Lead Sponsor
Abbott Medical Optics
Brief Summary

The purpose of this clinical trial is to evaluate the safety and effectiveness of the TECNIS Symfony Extended Range of Vision IOL.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
324
Inclusion Criteria
  • Minimum 22 years of age
  • Bilateral cataracts for which phacoemulsification extraction and posterior IOL implantation have been planned for both eyes
  • Preoperative best corrected distance visual acuity (BCDVA) of 20/40 Snellen or worse with or without a glare source
  • Potential for postoperative BCDVA of 20/30 Snellen or better
  • Corneal astigmatism
  • Clear intraocular media, other than cataract
  • Availability, willingness and sufficient cognitive awareness to comply with examination procedures
  • Signed informed consent and HIPAA authorization
  • Ability to understand and respond to a questionnaire in English or Spanish
Exclusion Criteria
  • Requiring an intraocular lens power outside the available range of +16.0 D to +28.0 D
  • Pupil abnormalities
  • Recent ocular trauma or ocular surgery that is not resolved/stable or may affect visual outcomes or increase risk to the subject
  • Prior corneal refractive or intraocular surgery
  • Corneal abnormalities
  • Inability to achieve keratometric stability for contact lens wearers
  • Subjects with diagnosed degenerative visual disorders that are predicted to cause visual acuity losses to a level of 20/30 Snellen or worse during the study
  • Subjects with conditions associated with increased risk of zonular rupture, including capsular or zonular abnormalities that may lead to IOL decentration or tilt, such as pseudoexfoliation, trauma, or posterior capsule defects
  • Use of systemic or ocular medications that may affect vision
  • Prior, current, or anticipated use during the course of the 6-month study of tamsulosin or silodosin, that may, in the opinion of the investigator, confound the outcome or increase the risk to the subject
  • Inability to focus or fixate for prolonged periods of time
  • Poorly-controlled diabetes
  • Acute, chronic, or uncontrolled systemic or ocular disease or illness that, in the opinion of the investigator, would increase the operative risk or confound the outcome(s) of the study.
  • May be expected to require retinal laser treatment or other surgical intervention during the course of the study
  • Patient is pregnant, plans to become pregnant, is lactating or has another condition associated with the fluctuation of hormones that could lead to refractive changes
  • Concurrent participation or participation within 30 days prior to preoperative visit in any other clinical trial
  • Desire for monovision correction

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
TECNIS Symfony Extended Range of Vision IOL, Model ZXR00TECNIS Symfony Extended Range of Vision IOL, Model ZXR00Bilaterally implanted with TECNIS Symfony Extended Range of Vision Intraocular Lens, Model ZXR00
TECNIS Monofocal IOL, Model ZCB00TECNIS Monofocal IOL, Model ZCB00Bilaterally implanted with TECNIS Monofocal Intraocular Lens, Model ZCB00
Primary Outcome Measures
NameTimeMethod
Distance Corrected Intermediate Visual AcuityAt 6 months

FDA has requested co-primary endpoints of distance corrected and uncorrected intermediate visual acuity.

Uncorrected Intermediate Visual Acuity6 months

Uncorrected Intermediate Visual Acuity at 6 months.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (15)

Virdi Eye Clinic & Laser Vision Center

🇺🇸

Rock Island, Illinois, United States

Empire Eye & Laser Center

🇺🇸

Bakersfield, California, United States

Jones Eye Clinic

🇺🇸

Sioux City, Iowa, United States

Eye Surgeons of Indiana

🇺🇸

Indianapolis, Indiana, United States

Ophthalmic Consultants of Long Island

🇺🇸

Rockville Center, New York, United States

Scott & Christie and Associates, PC

🇺🇸

Cranberry Township, Pennsylvania, United States

Whitsett Vision Group

🇺🇸

Houston, Texas, United States

Texas Eye and Laser Center

🇺🇸

Hurst, Texas, United States

Lehmann Eye Center

🇺🇸

Nacogdoches, Texas, United States

The Eye Center of Central PA

🇺🇸

Allenwood, Pennsylvania, United States

Eye Doctors of Washington

🇺🇸

Chevy Chase, Maryland, United States

Katzen Eye Care & Laser Center

🇺🇸

Boynton Beach, Florida, United States

Loden Vision Center

🇺🇸

Goodlettsville, Tennessee, United States

Boozman-Hof Regional Eye Clinic

🇺🇸

Rogers, Arkansas, United States

Cape Coral Eye Center

🇺🇸

Cape Coral, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath